医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

乳腺癌化疗期患者创伤后成长与癌症复发恐惧的相关性研究

Correlation between posttraumatic growth and fear of cancer recurrence in patients with breast cancer during chemotherapy

摘要目的:探讨乳腺癌化疗期患者创伤后成长与癌症复发恐惧的现状及其相关性。方法:采用一般情况调查表、中文版创伤后成长问卷(PTGI-C)和中文版癌症复发恐惧量表(FCRI-CV),对山东省泰安市中心医院和山东第一医科大学第二附属医院的208例乳腺癌化疗期患者进行横断面调查。结果:乳腺癌化疗期患者创伤后成长总分为(65.80 ± 12.36)分,处于中等水平,癌症复发恐惧总分为(79.52 ± 18.15)分,处于低-中等水平;乳腺癌化疗期患者的创伤后成长总分与癌症复发恐惧总分呈负相关( r值为-0.449, P<0.01)。 结论:乳腺癌化疗期患者创伤后成长与癌症复发恐惧密切相关,创伤后成长水平越高,其癌症复发恐惧感越低。这提示医护人员可通过提高患者的创伤后成长水平而降低其癌症复发恐惧。

更多

abstractsObjective:To investigate the relationship between posttraumatic growth and fear of cancer recurrence in patients with breast cancer during chemotherapy.Methods:The Posttraumatic Growth Inventory-C (PTGI-C) and the Fear of Cancer Recurrence Inventory-Chinese Version (FCRI-CV) were used in the Tai'an Central Hospital of Shandong Province and the Second Affiliated Medicine of Shandong First Medical University. A cross-sectional survey was conducted in 208 patients with breast cancer during chemotherapy.Results:The total score of posttraumatic growth of breast cancer patients during chemotherapy period was 65.80±12.36, which was at the middle level. The total score of fear of cancer recurrence was 79.52 ±18.15, which was at the low-medium level. The total score of posttraumatic growth of breast cancer patients during chemotherapy was negatively correlated with the total score of fear of cancer recurrence ( r=-0.449, P<0.01). Conclusion:Posttraumatic growth of breast cancer patients during chemotherapy is closely related to fear of cancer recurrence. The higher the level of posttraumatic growth, the lower the fear of cancer recurrence. This suggests that the fear of cancer recurrence can be reduced by improving the growth level of patients after trauma.

More
广告
  • 浏览322
  • 下载340
中国实用护理杂志

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷